Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Retractable Technologies Inc. (RVP) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Instruments & Supplies
$0.73
+0.02 (2.82%)Did RVP Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Retractable Technologies is one of their latest high-conviction picks.
RVP has shown a year-to-date change of -5.2% and a 1-year change of -7.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RVP. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for RVP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Retractable Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Retractable Technologies Inc. has a market capitalization of $21.85M with a P/E ratio of 8.1x. The company generates $37.90M in trailing twelve-month revenue with a -17.0% profit margin.
Revenue growth is -2.5% quarter-over-quarter, while maintaining an operating margin of -36.2% and return on equity of -8.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops safety medical devices for healthcare.
The company designs, manufactures, and markets safety medical devices, primarily retractable and injection needle systems. It generates revenue by selling these innovative products to hospitals, clinics, and other healthcare providers, focusing on minimizing risks associated with needle-stick injuries and cross-contamination.
Retractable Technologies Inc. is committed to improving public health and safety through its products and plays a significant role in influencing best practices in the medical device industry. The company's emphasis on technological innovation and quality positions it as a trusted partner within healthcare.
Healthcare
Medical Instruments & Supplies
221
Mr. Thomas J. Shaw
United States
2001
Retractable Technologies, Inc. declared dividends of $39,050 for Series II Class B and $18,561.25 for Series III Class B Convertible Preferred Stock, payable on January 20, 2026.
Retractable Technologies' dividend declaration signals financial stability and a commitment to returning value to shareholders, which can enhance investor confidence and stock demand.
Retractable Technologies reported improved Q3 2025 earnings due to enhanced margins, investment gains, and a transition to domestic production.
Improved earnings, better margins, and a shift to domestic production indicate stronger financial health and growth potential, positively influencing investor sentiment and stock performance.
Retractable Technologies' EasyPointยฎ Blood Collection Tube Holder has received an Innovative Technology designation from Vizient, highlighting its potential to enhance clinical care and safety in healthcare.
Retractable Technologies' EasyPointยฎ product recognition by Vizient could boost sales and market position, signaling growth potential and innovation in the healthcare sector, attracting investor interest.
Retractable Technologies, Inc. reported Q3 2025 net sales of $10.1 million and an operating loss of $3.7 million, improving from $10.3 million in sales and a $5.1 million loss last year. Year-to-date sales are $28.8 million with $13.5 million in losses.
Retractable Technologies shows slight sales decline but improved operating loss, indicating potential operational efficiency. Investors may view this as a positive trend in cost management despite lower revenue.
RVP reported stronger Q2 2025 sales and reduced losses, attributing the improvement to increased domestic production, which helped mitigate tariff impacts.
RVP's stronger sales and reduced losses indicate improved financial health, suggesting resilience against tariffs, which could boost investor confidence and stock performance.
Retractable Technologies, Inc. reported Q2 2025 net sales of $10.4M and an operating loss of $5.1M, improving from $6.0M in sales and a $5.8M loss in Q2 2024. H1 2025 sales totaled $18.7M, with losses at $9.8M.
Retractable Technologies shows revenue growth, increasing net sales from $6.0 million to $10.4 million, indicating potential recovery, despite ongoing operating losses.
Analyst forecasts for Retractable Technologies Inc. (RVP) are not currently available. The stock is trading at $0.73.
Analyst ratings for RVP are not currently available. The stock is currently trading at $0.73. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.
The company designs, manufactures, and markets safety medical devices, primarily retractable and injection needle systems. It generates revenue by selling these innovative products to hospitals, clinics, and other healthcare providers, focusing on minimizing risks associated with needle-stick injuries and cross-contamination.
Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.
Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.
Analyst ratings for RVP are not currently available. The stock is trading at $0.73.
Stock price projections, including those for Retractable Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.